The knowledge-to-action cycle: identifying the gaps by ProQuest


More Info
									                            CMAJ                                                                                                      Review
                          The knowledge-to-action cycle: identifying the gaps

                          Alison Kitson RN DPhil, Sharon E. Straus MD MSc

                                n a large study in the United States, 20% of people with
                                type 2 diabetes mellitus had poor control of blood glu-            Key points
                                cose (i.e., a hemoglobin A1c concentration greater than            •   Identifying the gaps from knowledge to practice is the
                          9%), only one third achieved a target rate of blood pressure                 starting point of implementing knowledge. Analyses of
                                                                                                       gaps should involve use of rigorous methods and engage
                          (i.e., 130/80 mm Hg) and half had low-density lipoprotein                    relevant stakeholders.
                          cholesterol levels above the target rate.1 Less than 50% of
                                                                                                   •   Strategies for completing needs assessments depend on
                          people with fragility fracture received a diagnostic test for                the purpose of the assessment, the type of data and the
                          osteoporosis or a diagnosis from a clinician.2 Among elderly                 resources that are available.
                          patients with hip, wrist or vertebral fractures, 10%–20%                 •   Needs can be assessed from the perspective of a
                          receive therapy for osteoporosis in the year after the frac-                 population, an organization or a health care provider.
                          ture.3 Researchers have found that evidence frequently isn’t
                          used by local,4 national5 or international6 policy-makers.
                                                                                                 ple of vascular risk, the availability of a computerized system
                          What is a “gap”?                                                       for support of decision-making in a clinician’s office is a
                                                                                                 structural indicator. Completion of a vascular risk assessment
                          All of the above facts are examples of gaps. Measuring the             by a patient or physician is a process indicator. Outcomes
                          “gap” between evidence and actual practice or policy-making            would include stroke, myocardial infarction and death. For
                          is one of the first steps in knowledge translation.7 By evi-           each of these items, ideally we would have a descriptive state-
                          dence, we mean the best available research-based evidence.8            ment, a list of data-based elements or criteria to measure the
                          Ideally, this evidence should come from high-quality practice          indicator, and information about the relevant population, how
                          guidelines or systematic reviews.                                      the data-based elements are collected, the timing of data col-
                              We’ll use a recent example from New Zealand to illustrate          lection and reporting, the analytic models used to construct
                          how to use data to address gaps — the difference between               the measure, the format in which the results will be presented
                          what is desired and what is actually done. For many years,             and the evidence in support of its use (Box 1).12
                          vascular guidelines in New Zealand have contained recom-                   Many countries have instituted national strategies to col-
                          mendations that management of cardiovascular risk should be            lect quality indicators.12 For example, the National Institute of
                          informed by the absolute risk of a cardiovascular event.9              Clinical Studies in Australia has captured gaps from evidence
                          Moreover, they targeted treatment to those with an absolute            to practice across a range of issues including influenza vacci-
                          cardiovascular risk of 15% or higher at 5 years. Researchers           nation.14 The Agency for Health Research and Quality in the
                          found that in primary care, less than one-third of people with         United States has prepared indicators to measure aspects of
                          vascular disease were receiving therapy recommended by the             quality in prevention, in-hospital care, patient safety and pedi-
                          guidelines.10                                                          atrics.15 However, little agreement exists on quality indicators
                              Before anything can be done to improve the quality of care,        across countries.
                          we need to be able to assess current care in a simple, reliable            Quality indicators should be developed through considera-
                          way. Quality indicators can be used as a basis for assessing           tion of the best available evidence. The Delphi method was
                          gaps. These indicators are measures used to monitor, assess            modified by investigators at RAND Health to achieve consen-
                          and improve the quality of care and organizational functions           sus on this process.16 The method involves rounds of anony-
                          that affect patient outcomes. Examples include appropriate             mous ratings on a risk–benefit scale and in-person discussion
                          control of blood pressure in patients with diabetes and previ-         between rounds.17 The goal is to be inclusive of all relevant
                          ous stroke, and prophylaxis against deep vein thrombosis in            stakeholders, including the public, health care professionals

                          critically ill patients admitted to the intensive care unit.
                              Donabedian11 proposed a framew
To top